- Citations, last 5 years
- 0
- Works, last 5 years
- 2
- h-index
- 0
- Scientists listed
- 0
- Grants since 2016
- 5
Grants received
2025–2026 · research · R41
Engineered Monothiol Thioredoxin for Treatment of Radiation Induced Lung Injury
Peter B Heifetz · Orpro Therapeutics (United States) · funded by National Institutes of Health
2022–2025 · grant · PRMRP
Development of Monothiol Human Thioredoxin-1 (ORP100S) as an Inhaled Treatment for Acute Viral Lung Injury
Peter Heifetz · Orpro Therapeutics (United States) · funded by Congressionally Directed Medical Research Programs
2018–2019 · research · R43
Mucoadhesive drug conjugates for controlled-release inhalation delivery
Peter B Heifetz · Orpro Therapeutics (United States) · funded by National Institutes of Health
2018 · research · R44
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis
Peter B Heifetz · Orpro Therapeutics (United States) · funded by National Institutes of Health
2018–2020 · research · R44
Development of modified human thioredoxin as an inhaled biologic therapeutic for cystic fibrosis
Peter B Heifetz · Orpro Therapeutics (United States) · funded by National Institutes of Health